Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Operating Income Loss of -$17.25 million for the year ending 2025.
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -95.0% in Operating Income Loss from 2024 to 2025.
- This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Operating Income Loss has declined by 316.0%.
- Historical annual values: Fiscal year 2025: -$17.25 million | Fiscal year 2024: -$8.84 million | Fiscal year 2023: -$21.80 million | Fiscal year 2022: -$11.79 million | Fiscal year 2021: -$8.82 million | Fiscal year 2020: -$25.88 million | Fiscal year 2019: $5.48 million | Fiscal year 2018: $13.59 million | Fiscal year 2017: $14.67 million | Fiscal year 2016: -$20.63 million | Fiscal year 2015: $18.46 million | Fiscal year 2014: $20.19 million | Fiscal year 2013: $24.87 million | Fiscal year 2012: $14.58 million | Fiscal year 2011: $8.03 million | Fiscal year 2010: $7.98 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: